German institute sanctions director after finding him guilty of misconduct

The executive board of the Leibniz Association in Germany has reprimanded the director of its institute on aging for “grossly negligent scientific misconduct.” Besides a written reprimand, the executive board has removed Karl Lenhard Rudolph’s “passive voting rights” in association committees, and excluded the institute under his leadership from receiving funds from a multi-million Euro internal … Continue reading German institute sanctions director after finding him guilty of misconduct

Former prof fudged dozens of images, says university

On Dec. 2, 2013, Alison Lakin, the research integrity officer at the University of Colorado Denver, received a concerning email. The emailer was alleging several problems in a 2012 paper in the Journal of Clinical Investigation, co-authored by one of its high-profile faculty members. Lakin discussed the allegations with some administrators and agreed they had … Continue reading Former prof fudged dozens of images, says university

Weekend reads: Science’s citation problem; researcher rehab; a strange new journal

The week at Retraction Watch featured the resignation of a researcher found to have fudged data in a study of Crossfit, and allegations of bullying by a scientist who wouldn’t let a trainee publish a paper. Here’s what was happening elsewhere:

Journal flags cancer paper from Karolinska researchers

A journal has issued an expression of concern (EOC) for a 2011 cancer paper, while Karolinska Institutet investigates “concerns” about some of the data. After the Journal of Cell Science (JCS) received a tip from a reader, it investigated, but was unable to resolve the concerns. So the journal asked KI–where all the authors work–to … Continue reading Journal flags cancer paper from Karolinska researchers

Springer purge of fake reviews takes down 10+ more neuroscience papers

Back in April, Springer retracted a record number 107 papers from Tumor Biology after uncovering evidence they were subject to fake peer reviews. But it appears that the Tumor Biology sweep was only part of the story. During the Tumor Biology investigation, Springer found evidence that the “peer review process was compromised” in a dozen papers … Continue reading Springer purge of fake reviews takes down 10+ more neuroscience papers

Weekend reads: A demand for a CRISPR paper retraction; a weak data-sharing policy; can we trust journals?

The week at Retraction Watch featured a study suggesting that 2% of studies in eight medical journals contained suspect data, and the announcement of a retraction on a professor’s blog. Here’s what was happening elsewhere:

“Data had been manipulated:” Science Translational Medicine retracts paper

Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated. The investigation occurred at the University of Basel. It’s not clear what prompted it, but the paper has been discussed at length on PubPeer. After the investigation concluded two figure panels included manipulated data, the last … Continue reading “Data had been manipulated:” Science Translational Medicine retracts paper

Rutgers prof announces retraction on his blog

A Rutgers computer scientist is retracting conference proceedings via an unusual channel: his personal blog. On April 7, Anand Sarwate wrote that he was retracting a mathematical proof from the proceedings from the 2016 IEEE International Conference on Acoustics, Speech, and Signal Processing (ICASSP), after discovering errors that invalidated the result. He explains in the blog … Continue reading Rutgers prof announces retraction on his blog

A retraction gets retracted — but the first author’s contract is still terminated

After issuing a retraction notice May 30 for a biomedical engineering paper, the journal has since pulled the notice, citing “a potential problem.” After doing some digging, we’ve learned more about the “potential problem.” Apparently, the retraction was requested by Nanyang Technological University (NTU) in Singapore. NTU has been investigating the first author for months, after it received … Continue reading A retraction gets retracted — but the first author’s contract is still terminated

Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study

A sweeping analysis of more than 5,000 papers in eight leading medical journals has found compelling evidence of suspect data in roughly 2% of randomized controlled clinical trials in those journals. Although the analysis, by John Carlisle, an anesthetist in the United Kingdom, could not determine whether the concerning data were tainted by misconduct or … Continue reading Two in 100 clinical trials in eight major journals likely contain inaccurate data: Study